ASP: Brand-name drugs see increase

Thursday, March 13, 2014

BALTIMORE – Two nebulizer medications will see payment increases for the second quarter of 2014. In the latest average sales price (ASP) figures, released March 4, brand-name drugs Brovana (J7605) and Perforomist (J7606) increased 37 cents and 55 cents respectively, to $6.14 and $6.91. That’s in contrast to budesonide (J7626), which decreased nearly 51 cents to $5.61 per dose. Other neb meds saw little change: albuterol (J7613) was up just over a penny to 13 cents per dose while ipratropium (J7644) stayed at just under 12 cents per dose.